Lefty your PP - 6 Alarming Findings in House Panel’s

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
219
Lefty your PP - 6 Alarming Findings
in House Panel’s Planned Parenthood Probe



Planned Parenthood affiliates profited by transferring parts of aborted babies to outside organizations in violation of the law, a special House panel has concluded after a yearlong investigation.

In a 418-page report released Wednesday, the House Select Investigative Panel on Infant Lives also found that other organizations involved in the transfer of fetal tissue broke federal or state law.

In one case, a national Planned Parenthood executive interviewed by staff investigators for the House panel said “it doesn’t bother me” that one vendor, StemExpress, paid Planned Parenthood $55 for an aborted baby’s intact brain and then sold it to a customer for more than $3,000.

“It’s none of my concern. It doesn’t bother me,” the Planned Parenthood executive said, according to the panel’s report.

Republican members of the House panel recommend that authorities pursue charges against Planned Parenthood affiliates, which receive taxpayer money, and other entities for violating the law and related regulations.

“It is my hope that our recommendations will result in some necessary changes within both the abortion and fetal tissue procurement industries,” the panel’s chairman, Rep. Marsha Blackburn, R-Tenn., said in a press release. “Our hope is that these changes will both protect women and their unborn children, as well as the integrity of scientific research.”

But the panel’s ranking member, Rep. Jan Schakowsky, D-Ill., denounced the report Tuesday as “illegitimate.” She said the panel’s eight Republican members drafted the report in secret without input from the panel’s six Democrats, who issued their own report last month.

“They have repeatedly made false claims,” Schakowsky said of Blackburn and Republicans, “including a series of ‘criminal referrals’ to federal, state, and local law enforcement officials based on unsourced, unverified documents and information.”

Specifically, the panel’s eight Republicans recommended a criminal investigation of Planned Parenthood of the Gulf Coast based on evidence it violated Texas and U.S. law in fetal tissue transactions.

They also made nine criminal and regulatory referrals in the cases of abortion providers and tissue procurement companies in Arkansas, California, and Ohio.

Finally, they recommended that Congress take steps to improve practices in biomedical research, such as by establishing ethical guidelines for using tissue from aborted babies.

Well before the House panel concluded its investigation of Planned Parenthood, the nation’s largest abortion provider, conservative groups had been calling for Congress to end use of federal taxpayers’ money to fund the organization.

With a new Republican administration beginning when Donald Trump is inaugurated as president Jan. 20, pro-life activists now see that as more than a possibility.

The GOP-led investigation began after the pro-life Center for Medical Progress published a series of undercover videos exploring the market for fetal tissue from aborted babies. The videos featured employees of StemExpress and Planned Parenthood discussing the sale of fetal tissue, sparking allegations that both organizations were profiting from such transactions.

StemExpress is a for-profit tissue procurement company based in Folsom, California.

Both the Planned Parenthood Federation of America and StemExpress denied illegal activity, although Planned Parenthood said it has stopped taking reimbursements for the cost of donating fetal tissue to companies such as StemExpress.

The new report details evidence that suggests Planned Parenthood and other entities crossed legal and ethical lines while in the fetal tissue market.

Planned Parenthood Federation of America did not respond to The Daily Signal’s request for comment on the report.

Below, The Daily Signal compiles six of the strongest findings, some featuring interviews between Planned Parenthood officials and the House panel’s top investigators:

1. Several Planned Parenthood affiliates made a profit from the transfer of aborted body parts and other fetal tissue, in violation of federal law prohibiting that.

The report says:

Accounting documents from middleman tissue organizations showed that several PPFA [Planned Parenthood Federation of America] affiliates made a profit from the transfer of fetal tissue.

The middleman investigation, and in particular the investigation of StemExpress, produced information about several PPFA affiliate clinics. In particular, it became clear that StemExpress was doing all the work to obtain consent for donation from individual patients, that StemExpress was doing the work of harvesting the fetal tissue after an abortion was complete, and that StemExpress was doing the work and passing on its costs of shipping to customers.

This raised a profound issue for the [House select] panel: Both the middleman and the PPFA affiliate clinic were claiming the same expenses against their revenue to show a loss on fetal tissue sales.

2. It didn’t “bother” a Planned Parenthood executive that one vendor, StemExpress, appeared to make a 2,800 percent profit on a baby’s brain harvested from a Planned Parenthood clinic.

Investigators questioned a Los Angeles abortion provider who also is a national Planned Parenthood executive, identified as PP Witness No. 1. These questions are about StemExpress making a profit in its contractual collaboration with Planned Parenthood affiliates after StemExpress sold aborted body parts and organs to customers.

The report says:

The questions were focused on the markup of an intact fetal brain from $55 paid to the Planned Parenthood affiliate versus the $3,340 charged to the customer:

Q: Now, here’s the scenario, and we’ll be done. Tissue tech learns who’s available for contributing. She goes and gets the consent. She gets paid a bonus. The Planned Parenthood clinic, I believe, gets $55, but it’s in the range of [$]30 to [$]100, and StemExpress resells that brain for over $3,000.

And you’ll notice—you may notice on there [the invoice] that the shipping and maybe some other things are paid for by the customer.

Now, does that bother you?

A: No.

Q: Well, if they—if it was a profit would it bother you?

A: It’s really none of my business, no.

Q: Is that a concern to you? … And here’s a more granular example. It looks like StemExpress, who for several years only did abortion clinics, now they do lots of stuff, lots of other stuff. But for several years of their life they only got tissue from [Planned Parenthood] Mar Monte, Shasta Pacific, and resold it at prices like this.

And I just want to know what’s sort of the global management perspective of a Planned Parenthood senior leader like you if that’s a 2,800 percent profit.

Would that bother you?

A: So just so that I’m clear on the question[;] you’re asking me if it bothers me that StemExpress makes money reselling the tissue?

Q: Yeah.

A: It’s none of my concern. It doesn’t bother me.

3. Planned Parenthood abortion doctors would huddle with a tissue procurement technician from Novogenix to learn what aborted body parts that outside person was searching for that day.

Investigators questioned a Los Angeles Planned Parenthood abortion provider (PP Witness No. 1) who also works for the Medical Directors’ Council. She answered questions about meetings she had with Novogenix, a tissue procurement company, prior to performing abortions to determine the type of tissue that its technicians wanted that day.

The report says:

Q: Now, do you think that doctors in your position should huddle in the morning? You say, ‘I like to do that.’ It’s sort of an ongoing tense. Do you think the doctors should huddle with a tissue tech to see what they’re procuring, [what] is on their list that day?

A: I don’t really have a feeling as to whether other doctors did. I like to be helpful.

Q: And so you found it helpful that at least on this one day to huddle with the tissue tech and learn what [the Novogenix employee] was searching for, what orders she had; is that right?

A: I would ask her what tissue she was looking for, yes.

Q: All right. Do you think that’s a good idea for the whole fetal tissue donation program, that doctors and the tissue techs huddle each morning to discuss what they’re going to try and procure that day?

A: I think it could be helpful.

4. Planned Parenthood doctors appear to have altered their techniques to increase the chances of success in harvesting tissue from abortions that day.

Investigators questioned the same Planned Parenthood abortion provider in Los Angeles about whether she changed procedures to increase the likelihood of a successful procurement of specific tissue.

From the report:

Q: ‘There are little things they can make in their technique to increase your success.’ What are those little things?

A: Again, as I mentioned, a change in instruments, a change in where they’re grasping the tissue. These are changes in technique that a provider can make for a variety of reasons. I—

Q: But it could be made to increase the success of fetal tissue donation.

A: Yes, that’s what I’m saying.

Q: OK. Now, so those little techniques that you just described, if there was no fetal tissue donation to increase the likelihood of success, they wouldn’t—they wouldn’t make those little changes, would they?

A: Well, providers make changes in technique for a variety of reasons.

Q: Now, the question is: If there was no fetal tissue donation, those little things, changes that would be made to increase their likelihood of success, those wouldn’t be made, would they?

A: Well, I can’t say across the board they wouldn’t be made because there’s probably other reasons that a provider during a procedure—

Q: They wouldn’t be made for the purpose of getting fetal tissue, would they?

A: No, they wouldn’t.

Q: So they would be made for other reasons.

A: Yes.

Q: So one set of little changes is chosen for other medical reasons, and one set of little changes could be chosen to increase the likelihood of success.

A: Yes.

5. Planned Parenthood’s consent form is “inadequate compared to other entities’ consent forms.”

Investigators concluded that Planned Parenthood’s one-page consent form contains “widely inaccurate claims about past results from fetal tissue research.” They also said the consent form “fails to provide basic information about the purpose for which the [tissue] donation is being sought and the precise nature of the ‘pregnancy tissue’ being donated.”

According to the report:

Numerous witnesses, including senior [Planned Parenthood Federation of America] officials, testified that the consent form is misleading and unethical due to its contention that fetal tissue has been used to find a cure for diabetes, Parkinson’s disease, Alzheimer’s disease, cancer, and AIDS.

The Los Angeles Planned Parenthood abortion provider, who is also in charge of the national organization’s Manual of Medical Standard and Guidelines, said:

If I’m evaluating the form now, you are correct. To my knowledge there is no cure for AIDS. So that is probably an inaccurate statement. … a consent form should not have an incorrect statement.

The report says another witness, a manager of research projects at Planned Parenthood Gulf Coast identified as PP Witness No. 2, testified: “I would agree that that is insufficient for obtaining informed consent, correct.”

6. Planned Parenthood affiliate clinics “routinely” violated privacy regulations imposed by the Health Insurance Portability and Accountability Act of 1996, seeking to ease the process of harvesting body parts and other fetal tissue.

From the House panel’s report:

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy rule (Privacy Rule) protects all individually identifiable health information held or transmitted by a covered entity or its business associate and calls this information protected health information (PHI). PHI identifies an individual, or can reasonably be believed to be useful in identifying an individual, and includes demographic data relating to an individual’s health condition, provision of health care, or payment for the provision of health care to the individual.

The panel’s investigation indicates that StemExpress and Planned Parenthood Mar Monte (PPMM), Planned Parenthood Shasta Pacific (PPSP), and Family Planning Specialists Medical Group (FPS) committed systematic violations of the HIPAA Privacy Rule from about 2010 to 2015.

These violations occurred when the abortion clinics disclosed patients’ individually identifiable health information to StemExpress to facilitate the [tissue procurement business’] efforts to procure human fetal tissue for resale.




Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 94

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
Boardwalk Welcomes New CFO: What This Means for Growth

Updated Category News Views 77

Boardwalk's Leadership Shift: Enter Scott Wexler Nothing spices up a pipeline company's menu like a fresh plate of leadership. Boardwalk Pipelines, out in Houston, just handed the keys to their finance dungeon over to Scott Wexler. He's stepping in as the chief financial officer and senior VP of corporate strategic development, an upgrade that got announced today. Packing...

Continue Reading
EzAccounting: Your Q3 IRS Filing Gets a No-Nonsense Tool

Updated Category News Views 19

Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 29

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
LUNGevity's Bold $1M Bet on Lung Cancer Research

Updated Category News Views 24

Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 17

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Navigating Gas-to-AI Power: Challenges & Opportunities

Updated Category News Views 19

Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 67

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
Fed Holds Steady, But CD Rates Climb: Savers' Edge

Updated Category News Views 37

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

Continue Reading
Rothera's KPI Swap Approval: A Financial Game Changer

Updated Category News Views 107

Revolutionizing Risk Management with KPI Swaps Boy, if there's one thing that gets my ticker going, it's the buzz of innovation in financial markets. Rothera just landed a CFTC stamp of approval for something that's about to shake up how institutional traders manage risk: Key Performance Indicator (KPI) swaps. And can you believe it? This isn't just another derivative...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Momentum: Accenture's Strong Earnings Impact Stocks

Updated Category News Views 73

Market Overview: U.S. Stock Dynamics U.S. stocks saw a positive trend with the Dow Jones index experiencing a significant rise of over 250 points in recent trading sessions. Index Performance On this day, the Dow Jones Industrial Average rose by 0.63%, concluding at 42,177.28. Similarly, the NASDAQ increased by 0.54% to reach 18,179.88, while the S&P 500 also saw gains of...

Continue Reading
Exploring Technology for Good: Insights from AI Experts

Updated Category News Views 213

Understanding the Concept of Technology for Good Amidst the fast-evolving landscape of artificial intelligence (AI), one individual stands out for their insights into how technology can profoundly benefit humanity. As a member of the UN advisory body on AI, Zhang Linghan, a seasoned professor, presents a comprehensive view on the philosophy of 'technology for good...

Continue Reading
Corporate America Faces Challenges in Women's Workplace Progress

Updated Category News Views 205

Navigating the Future for Women in the Workplace In a rapidly changing world, the dynamics of the workplace continue to evolve, especially for women. The latest insights underline significant potential setbacks in corporate America that could undermine the progress achieved in recent years. Organizations that once championed diversity and inclusion are at a crossroads,...

Continue Reading
Barington Capital Urges Matthews International Shareholders to Act

Updated Category News Views 221

Barington Capital Urges Matthews International Shareholders to Act Barington Capital Group, L.P., an activist investment firm, is taking the initiative to address the governance concerns at Matthews International Corporation. The firm, owning about 2.2% of Matthews' common stock, has sent a compelling message to shareholders, urging them to elect their director nominees...

Continue Reading
Key Insights from Sampo plc's Annual General Meeting Proposals

Updated Category News Views 193

Overview of the Annual General Meeting Proposals Sampo plc has provided essential insights into the proposals for their upcoming Annual General Meeting (AGM), reflecting the company's strategic initiatives for the upcoming financial year. These proposals stem from the Board of Directors and the Audit Committee, aiming to enhance operational efficiency and shareholder...

Continue Reading